Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
111.11
+1.66 (+1.52%)
Official Closing Price
Updated: 7:00 PM EST, Jan 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
12,844,343
Open
109.19
Bid (Size)
110.90 (100)
Ask (Size)
111.00 (100)
Prev. Close
109.45
Today's Range
108.73 - 111.97
52wk Range
73.31 - 112.90
Shares Outstanding
2,531,374,696
Dividend Yield
3.06%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Moderna Stock Surged Today
↗
Today 19:11 EST
The vaccine maker is expanding beyond its COVID-focused offerings.
Via
The Motley Fool
Merck Shares Rise On $30M Funding From CEPI To Develop Affordable Ebola Vaccine
↗
Today 14:27 EST
CEPI will provide Merck with $30 million and Merck will, in turn, leverage its joint venture with Wellcome, called Hilleman Laboratories, to develop an Ebola vaccine with an updated manufacturing...
Via
Stocktwits
Topics
Workforce
Performance
YTD
+4.4%
+4.4%
1 Month
+6.1%
+6.1%
3 Month
+26.8%
+26.8%
6 Month
+32.3%
+32.3%
1 Year
+15.5%
+15.5%
More News
Read More
Moderna Stock Still Worth 37% Less After Cancer Vaccine Data? BofA’s New Price Target Keeps Retail Traders Cautious
↗
January 20, 2026
Via
Stocktwits
Moderna Shares Rise On Five-Year Follow-Up Takeaways For Skin Cancer Vaccine: Retail Applauds ‘Solid’ Update
↗
January 20, 2026
Via
Stocktwits
ABUS Stock On Track For Biggest Intraday Drop In Over 5 Years – What’s The Issue Around Its Patent In Europe?
↗
January 16, 2026
Via
Stocktwits
Topics
Intellectual Property
Merck & Co. Inc. (NYSE:MRK) Presents a Compelling Value Investment Case
↗
January 14, 2026
Via
Chartmill
Merck In Talks To Acquire Revolution Medicines For About $30B: Report
↗
January 09, 2026
Via
Stocktwits
GSK Challenges Xolair Dominance with $2.2 Billion Acquisition of RAPT Therapeutics
January 20, 2026
Via
MarketMinute
Topics
Intellectual Property
Moderna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Patients With High-Risk Stage III/IV Melanoma Following
January 20, 2026
Via
ACCESS Newswire
3 “Forever Stocks” to Hold When the Market Won’t Sit Still
↗
January 19, 2026
Via
MarketBeat
The New Era of Johnson & Johnson: A 2026 Deep-Dive Research Feature
January 19, 2026
Via
Finterra
Topics
Artificial Intelligence
Bankruptcy
Economy
3 Profitable Stocks to Consider Right Now
January 18, 2026
Via
StockStory
The mRNA 2.0 Inflection: A Deep Dive into Moderna (MRNA) as it Faces a Critical 2026
January 16, 2026
Via
Finterra
Topics
Initial Public Offering
Intellectual Property
Lawsuit
2 Unpopular Stocks That Should Get More Attention and 1 We Brush Off
January 15, 2026
Via
StockStory
The Execution Engine: How Merck is Dominating the 2026 Pharma Landscape
January 15, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
Healthcare Titan Ascendant: Johnson & Johnson Hits All-Time Highs as It Navigates a New Political and Clinical Era
January 15, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Bankruptcy
Earnings
A Whole Watchlist of “Coiled Springs” (Found With One Simple ChartMill Screen)
↗
January 15, 2026
Via
Chartmill
Moderna’s High-Stakes Transformation: Navigating the Post-Pandemic Pivot
January 14, 2026
Via
Finterra
Topics
Initial Public Offering
Intellectual Property
The mRNA Pivot: Moderna Navigates Regulatory Headwinds and Tariff Turmoil in a Volatile 2026 Biotech Landscape
January 12, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
World Trade
Revolution Medicines Dismisses Merck, Abbvie Buyout Talks While Analyst Say It Is Worth More Than $32B
↗
January 12, 2026
Via
Stocktwits
The AI-Bio Convergence: Lilly and Nvidia Kick Off JPM26 with Landmark $1 Billion Alliance
January 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Intellectual Property
3 Dividend Stocks to Hold for the Next 10 Years
↗
January 12, 2026
Via
The Motley Fool
Topics
Bonds
1 Momentum Stock Worth Your Attention and 2 Facing Headwinds
January 11, 2026
Via
StockStory
This ETF Is Proof That the Healthcare Rebound Is Real
↗
January 11, 2026
Via
MarketBeat
Topics
ETFs
Why Revolution Medicines Stock Surged by 11% Today
↗
January 09, 2026
Via
The Motley Fool
Topics
Intellectual Property
Frequently Asked Questions
Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 111.11
When was Merck & Co last traded?
The last trade of Merck & Co was at 01/21/26 07:00 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 281.26B
How many shares of Merck & Co are outstanding?
Merck & Co has 281B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.